Cita APA (7a ed.)

Tang, M., Song, C., Zhang, Y., Xu, X., Wang, C., Zhang, Z., & Chen, T. (2021). Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinib. BMC.

Cita Chicago Style (17a ed.)

Tang, Mengqiu, Chao Song, Yaowen Zhang, Xiaoyu Xu, Chen Wang, Zhanchun Zhang, y Tian Chen. Levels of Pretreatment Blood Lipids Are Prognostic Factors in Advanced NSCLC Patients Treated with Anlotinib. BMC, 2021.

Cita MLA (8a ed.)

Tang, Mengqiu, et al. Levels of Pretreatment Blood Lipids Are Prognostic Factors in Advanced NSCLC Patients Treated with Anlotinib. BMC, 2021.